NEW YORK (GenomeWeb) – Molecular diagnostics developer Castle Biosciences said today that it has expanded its credit facility with Silicon Valley Bank to $14 million.

The new facility refinances the company's existing $6 million loan, and adds $2 million in capital for new growth and a $5 million accounts receivable revolver loan. Castle said it will use the money to accelerate the development of its cutaneous melanoma test, DecisionDx-Melanoma, and to speed up new projects in its molecular diagnostic pipeline.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.